Phase I Study of Nimotuzumab in Combination With Simultaneous Chemotherapy and Radiation for Patients With Locally Advanced Esophageal Cancer.
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2015
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Fluorouracil
- Indications Oesophageal cancer
- Focus Adverse reactions
- Sponsors Biotech Pharmaceutical
- 18 Aug 2015 Treatment arm Nimotuzumab + cisplatin + fluorouracil + radiotherapy has been replaced with Nimotuzumab.
- 18 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2009 New trial record